seretide diskus 50100 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.
seretide diskus 50500 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 500 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. seretide (50/500 mcg) is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.
seretide diskus 50250 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 250 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. seretide (50/250 mcg) is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.
seretide 250 evohaler 25 microgram/250 microgram/dose pressurised inhalation, suspension
glaxosmithkline (ireland) limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - salmeterol and fluticasone
seretide 50 evohaler 25 microgram/50 microgram/dose pressurised inhalation, suspension
glaxosmithkline (ireland) limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/50 microgram(s)/dose - salmeterol and fluticasone
lifsar pulmojet
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - salmeterol, fluticasone propionate - inhalation powder - salmeterol 50 µg fluticasone propionate 500 µg - drugs for obstructive airway diseases
aloflute 25microgram/125microgram per metered dose pressurised inhalation, suspension
3m health care ltd - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/125microgram - adrenergics and other anti-asthmatics - is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate
aloflute 25 microgram/250 microgram per metered dose pressurised inhalation, suspension
3m health care ltd - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/250microgram - adrenergics and other anti-asthmatics - it is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate
sirdupla 25microgram/125microgram per metered dose pressurised inhalation, suspension
generics [uk] limited t/a mylan - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/125microgram - adrenergics and other anti-asthmatics - it is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate
sirdupla 25microgram/250microgram per metered dose pressurised inhalation, suspension
generics (uk) ltd t/a mylan - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/250microgram - adrenergics and other anti-asthmatics - it is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate